Crossmark

ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS

Crossref DOI link: https://doi.org/10.1245/s10434-022-12272-y

Published Online: 2022-07-21

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakhlis, Faina https://orcid.org/0000-0003-4752-0161
Katlin, Fisher D.

Grossmith, Samantha C.

DiPasquale, Ashley

Harrison, Beth T.

Schnitt, Stuart J.

King, Tari A.
License Information

Text and Data Mining valid from 2022-07-21

Version of Record valid from 2022-07-21
More Information

Article History

First Online: 21 July 2022

Disclosure

: Tari A. King reports speakers honoraria and an advisory board role for Exact Sciences (formerly Genomic Health) and is on the global advisory board of Besins Healthcare. Faina Nakhlis, Fisher D. Katlin, Samantha C. Grossmith, Ashley DiPasquale, Beth T. Harrison, and Stuart J. Schnitt have no conflicts of interest to declare.

: This research was approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board (study # 16-161).

Document is current

Any future updates will be listed below